Lite Strategy, Inc. Deferred Tax Assets, Deferred Income
Lite Strategy, Inc. (LITS) had Deferred Tax Assets, Deferred Income of $0 as of 2024-06-30, per its 10-K filed 2024-09-19.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2024-09-19
- 2024-06-30: Deferred Tax Assets, Deferred Income $0.00.
- 2023-06-30: Deferred Tax Assets, Deferred Income $14.07M.
- 2022-06-30: Deferred Tax Assets, Deferred Income $20.36M.
- 2021-06-30: Deferred Tax Assets, Deferred Income $16.64M; Deferred Tax Assets, Deferred Income as first filed $18.34M.
| Period end | Deferred Tax Assets, Deferred Income | Deferred Tax Assets, Deferred Income as first filed |
|---|---|---|
| 2024-06-30 | $0.00 10-K · filed 2024-09-19 | |
| 2023-06-30 | $14.07M 10-K · filed 2024-09-19 | |
| 2022-06-30 | $20.36M 10-K · filed 2023-09-26 | |
| 2021-06-30 | $16.64M 10-K · filed 2022-09-08 | $18.34M 10-K · filed 2021-09-02 |
| 2020-06-30 | $17.57M 10-K/A · filed 2022-05-23 | $17.32M 10-K · filed 2020-09-09 |
| 2019-06-30 | $1.64M 10-K · filed 2020-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |